The Development and Evaluation of Health Behavior Change Model and Mobile health Management Model for Patients with Coronary Heart Disease

Conditions

Coronary heart disease

Yuling Chen, Meihua Ji, Ying Wu, Qingyu Wang, Ying Deng et al. (11 authors)

JMIR mhealth and uhealth2021-12-138 citations

Individualized mobile health interventions for cardiovascular event prevention in patients with coronary heart disease: study protocol for the iCARE randomized controlled trial.

Chen Y, Ji M, Wu Y, Deng Y, Wu F, Lu Y.

2021-07-1310 citations

10.1186/s12872-021-02153-9

Development of interventions for an intelligent and individualized mobile health care system to promote healthy diet and physical activity: using an intervention mapping framework.

Chen Y, Wu F, Wu Y, Li J, Yue P, Deng Y, Lamb KV, Fong S, Liu Y, Zhang Y.

2019-10-1711 citations

10.1186/s12889-019-7639-7

Interventions

iCare Management group:Using CHD iCare mobile health management system to maintain health behavior for Patients with coronary heart disease after discharge

Control group 1:Participants in control group 2 will receive routine care and be asked to install the iCARE-3 before they are discharged.

Control group 2 :Participants in control group 2 will receive routine care and be asked to install the iCARE-3 before they are discharged.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients will be included in the study if they: (a) are 18 years or older; (b) have a documented diagnosis of CHD including acute myocardial infarction (AMI), acute coronary syndrome (ACS), or undertake a percutaneous coronary intervention (PCI) either as emergency or elective procedures; (c) have at least one smartphone with Android system and use it daily, and (d) agree to participate.

Exclusion criteria

Exclusion criteria: Patients who are (1) with a history of psychiatric and neurological disorders; (2) unable to speak or understand Mandarin; (3) illiterate; (4) with impaired bilateral hearing, or visual impairment which limits the use of smartphone; (5) with contraindications or severe physical disabilities that limit patients from participation; (6) with severe medical conditions; (7) participating in other ongoing clinical trials or prospective cohort studies; (8) additional exclusion criteria will be applied if patients are not able to understand the procedure and the aims of the study after full explanation, or not able to fill in the questionnaires during the baseline visits.

Design outcomes

Primary

Measure	Time frame
The incidence of major cardiovascular events within 3 years of discharge;	—

Secondary

Measure	Time frame
Healthy diet;Physical activity;Smoking cessation;Adherence to secondary preventive medications;Cardiovascular health;Anthropometry parameters, include weight (kg), body mass index (kg/m2), waist circumference (cm), waist-hip ratio.;Biochemical parameters, include total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, HbA1c, systolic blood pressure, diastolic blood pressure, heart rate.;10-year Framingham risk scores (FRS) of cardiovascular risks;All cause readmission;All cause readmission;Frequency of medical treatment due to CVD;Patients’ engagement in the intervention;Risk perception;Outcome expectation;Action planning;Coping planning;Behavioral enjoyment;Social support;Self-efficacy;Effectiveness perception;Intentions;Motivation;Volition;Stages of behavior change;Knowledge of coronary artery disease;Perceived importance of health behaviors;	—

Measure

Time frame

Healthy diet;Physical activity;Smoking cessation;Adherence to secondary preventive medications;Cardiovascular health;Anthropometry parameters, include weight (kg), body mass index (kg/m2), waist circumference (cm), waist-hip ratio.;Biochemical parameters, include total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, HbA1c, systolic blood pressure, diastolic blood pressure, heart rate.;10-year Framingham risk scores (FRS) of cardiovascular risks;All cause readmission;All cause readmission;Frequency of medical treatment due to CVD;Patients’ engagement in the intervention;Risk perception;Outcome expectation;Action planning;Coping planning;Behavioral enjoyment;Social support;Self-efficacy;Effectiveness perception;Intentions;Motivation;Volition;Stages of behavior change;Knowledge of coronary artery disease;Perceived importance of health behaviors;

—

Countries

China

Contacts

Public ContactYing Wu

Capital Medical University

helenywu@vip.163.com+86 13910789837

Outcome results

None listed